Matthew Alcusky to Anticoagulants
This is a "connection" page, showing publications Matthew Alcusky has written about Anticoagulants.
Connection Strength
2.294
-
Chen Q, Baek J, Goldberg R, Tjia J, Lapane K, Alcusky M. To treat or not to treat: a comparative effectiveness analysis of oral anticoagulant outcomes among U.S. nursing home residents with atrial fibrillation. BMC Geriatr. 2024 Jul 19; 24(1):619.
Score: 0.686
-
Chen Q, Lapane K, Nunes AP, Tjia J, Hugunin J, Alcusky M. Prevalence and the factors associated with oral anticoagulant use among nursing home residents. J Clin Pharm Ther. 2021 Dec; 46(6):1714-1728.
Score: 0.562
-
Alcusky M, McManus DD, Hume AL, Fisher M, Tjia J, Lapane KL. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016. J Am Heart Assoc. 2019 05 07; 8(9):e012023.
Score: 0.478
-
Chen Q, Baek J, Goldberg R, Tjia J, Lapane K, Alcusky M. Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment. J Am Geriatr Soc. 2023 10; 71(10):3071-3085.
Score: 0.160
-
Alcusky M, Baek J, Tjia J, McManus DD, Lapane KL. Geographic Variation in Anticoagulant Use and Resident, Nursing Home, and County Characteristics Associated With Treatment Among US Nursing Home Residents. J Am Med Dir Assoc. 2021 01; 22(1):164-172.e9.
Score: 0.134
-
Alcusky M, Tjia J, McManus DD, Hume AL, Fisher M, Lapane KL. Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents. J Gen Intern Med. 2020 08; 35(8):2329-2337.
Score: 0.127
-
Alcusky M, Hume AL, Fisher M, Tjia J, Goldberg RJ, McManus DD, Lapane KL. Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs Aging. 2018 12; 35(12):1089-1098.
Score: 0.116
-
Jayaraman DK, Alcusky M, Moonis M. Letter by Jayaraman et al Regarding Articles, "Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants" and "Effectiveness and Safety of Oral Anticoagulants among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study". Stroke. 2019 06; 50(6):e154-e155.
Score: 0.030